Interrogation device evaluation(s), (remote) up to 30 days; subcutaneous cardiac rhythm monitor system, including analysis of recorded heart rhythm data, analysis, review(s) and report(s) by a physician or other qualified health care professional
CPT4 code
Name of the Procedure:
Interrogation Device Evaluation(s) (Remote) Up to 30 Days; Subcutaneous Cardiac Rhythm Monitor System, Including Analysis of Recorded Heart Rhythm Data, Analysis, Review(s), and Report(s) by a Physician or Other Qualified Health Care Professional
Summary
This procedure involves the remote monitoring and evaluation of a subcutaneous cardiac rhythm monitor system over a period of up to 30 days. A healthcare professional reviews the recorded heart rhythm data, performs analyses, and generates reports based on the device’s findings.
Purpose
The procedure is used to continuously monitor and evaluate the heart's rhythm to detect arrhythmias or other cardiac issues. The primary goals are to diagnose potential heart rhythm disorders, manage ongoing cardiac conditions, and prevent complications from undetected arrhythmias.
Indications
- Patients with unexplained palpitations
- Syncope (fainting) episodes
- Suspected arrhythmias not captured during standard monitoring
- Continuous monitoring for patients with known cardiac arrhythmias
- Patients recovering from a myocardial infarction or cardiac surgery
Preparation
- No specific fasting or dietary restrictions are generally required.
- Patients may be instructed to maintain a symptom diary.
- Ensure the subcutaneous cardiac monitor is functioning correctly.
- No significant medication adjustments unless advised by a physician.
Procedure Description
- Data Collection: The subcutaneous cardiac rhythm monitor continuously records heart rhythm data for up to 30 days.
- Transmission: The data is transmitted remotely to a healthcare facility.
- Analysis: A physician or qualified healthcare professional analyzes the recorded data, identifying any abnormalities or arrhythmias.
- Review and Report: The results are reviewed, and a detailed report is prepared, including any relevant findings and recommendations for further action.
Duration
The monitoring period typically lasts up to 30 days, with periodic data reviews and a final comprehensive report at the end of the monitoring period.
Setting
The procedure is overseen remotely, while the patient remains in their daily environment. Data analysis and report generation occur in a healthcare facility such as a hospital or a specialized outpatient clinic.
Personnel
- Physician or Cardiologist
- Qualified healthcare professionals trained in cardiac data analysis
Risks and Complications
- Rarely, there may be skin irritation at the monitor site.
- There is a very minimal risk of the device malfunctioning.
- False positives or negatives could lead to additional unnecessary testing or missed diagnoses.
Benefits
- Continuous and comprehensive heart rhythm monitoring over an extended period.
- Early detection and management of potential serious cardiac conditions.
- Non-invasive with minimal patient discomfort.
Recovery
- No specific recovery process required, as this is a non-invasive monitoring procedure.
- Patients are generally advised to continue their normal activities and to follow any specific instructions provided in the report.
Alternatives
- Holter monitor for short-term heart monitoring.
- Event monitors for intermittent symptoms.
In-hospital telemetry for continuous bedside monitoring.
Pros of the subcutaneous monitor: Provides long-term monitoring and is less obtrusive.
Cons: Requires implantation and may need remote patient coordination.
Patient Experience
- Patients may initially feel slight discomfort at the monitor implantation site.
- Minimal daily discomfort; the device is designed to be discreet and non-intrusive.
- Regular activities are typically unaffected, but patients should report any unusual symptoms or device concerns to their healthcare provider.